9th Annual Biomarkers Congress
AACR Annual Meetings
Washington Convention Center

District of Columbia, Washington
http://www.aacr.org/meetingcalendar
AACR Annual Meetings
AACR
Washington Convention Center
District of Columbia
Washington
US


   N/A

   AACR
   American Association for Cancer Research

   Upcoming Conferences at the Forefront of Cancer Research

   Future AACR Annual Meetings

   April 6-10, 2013
   Washington, DC

   Please visit http://www.aacr.org/meetingcalendar often for additional
   conferences and program updates.

Schedule of Presentations:

Saturday, April 6, 2013
10:00:00 Cancer Immunology for the Non-Immunologist - Tutorial (Educational Session)
10:15:00 Advances in High Resolution Optical Microscopy (Methods Workshop)
10:30:00 Eighth Annual Undergraduate Student Caucus and Poster Competition (Professional Advancement Session)
12:00:00 16th Annual Grant Writing Workshop (Professional Advancement Session)
13:00:00 Building Presence and Leadership Through Empowered Communication (Professional Advancement Session)
14:00:00 Evaluating Cancer Vaccines and Immunotherapy Products at FDA/CBER (Science Policy Session)
15:15:00 Can Mouse Cancer Models Improve Clinical Medicine? (Educational Session)
15:15:00 Cellular Consequences of Aneuploidy and Aneuploidy as a Target for Cancer Therapy (Meet-the-Expert Session)
16:30:00 Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia (Meet-the-Expert Session)
17:00:00 Birthday Celebration for James D. Watson (Special Session)
17:15:00 Sixteenth Annual AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship (Lecture)
17:30:00 Fifty-Third Annual AACR-G.H.A. Clowes Memorial Award (Lecture)
17:30:00 Careers in Clinical and Translational Research Roundtable (Professional Advancement Session)
20:00:00 Cancer Genomics in the Clinic (Educational Session)
Sunday, April 7, 2013
07:00:00 Biomarkers of Resistance to Endocrine Treatments in Breast Cancer (Meet-the-Expert Session)
08:15:00 Seventh Annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research (Award Presentation)
09:00:00 Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Roel Nusse­, Elaine Fuchs, Richard J Gilbertson, Stuart H. Orkin
09:00:00 The MICR Scientific Symposium: Why Are Aggressive Forms of Cancer More Common Among Certain Racial/Ethnic Groups? Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA, and A. William Blackstock, Wake Forest University School of Medicine, Winston-Salem, NC Adeyinka O. Laiyemo, Christine B Ambrosone, Curtis C. Harris, Rick A. Kittles
09:00:00 Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson, Guido Kroemer, Peter D Senter, Timothy J Mitchison
09:00:00 Molecular Targets for the Prevention and Treatment of Tumors Caused by Oncogenic Viruses Chairperson: Douglas R. Lowy, National Cancer Institute, Bethesda, MD John Ward, Roland Schmitz, Douglas R. Lowy
09:00:00 Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong, Kristian Helin, Richard A. Young, Charles W. M. Roberts
09:00:00 Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Mikala Egeblad, Joan S Brugge, Gary Johnson
09:00:00 The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Michael M Shen, Hui Zong, Leonard I. Zon
09:00:00 The Global Cancer Crisis: Needs and Opportunities for Prevention Chairperson: John D. Groopman, Johns Hopkins University School of Public Health, Baltimore, MD John D Groopman
09:00:00 Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Stephen Fesik, Loren Walensky, Shaomeng Wang, Domagoj Vucic
09:00:00 Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Garry P Nolan, Robert Singer, Ulf Landegren, Claude Lechene
09:00:00 Imaging the Cancer Cell In Vivo Chairperson: Ralph Weissleder, Massachusetts General Hospital, Boston, MA Sanjiv S. Gambhir, Ralph Weissleder, Tannishtha Reya, John S Condeelis
09:00:00 Innate Immune Sensing in the Tumor Microenvironment Chairperson: Thomas Frank Gajewski, University of Chicago, Chicago, IL Thomas F Gajewski, Caetano Reis e Sousa, David Raulet
09:00:00 New FROM DISCOVERY SCIENCE TO PRECISION MEDICINE: PAVING THE PATH TO PROGRESS Hans Clevers, Charles M. Perou, Suzanne L. Topalian, Siddhartha Mukherjee
09:00:00 Analysis of Cancer Genome Data: From Evolution to Pathways and Networks Paul T. Spellman, Joshua M. Stuart, Li Ding
09:00:00 The Bayard D. Clarkson Symposium on Stem Cells and Cancer: Stem Cell Biology and Therapeutics Emmanuelle Passegué, Cedric Blanpain, Eduard Batlle, John E. Dick
09:00:00 Blood-Based Molecular Analysis of Cancer Victor E Velculescu, Carlos Caldas, Luis A Diaz, Daniel A Haber
09:00:00 BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Roger S. Lo, Martin McMahon, Deborah Morrison, Richard M Marais
09:00:00 Building on the Success of CTLA-4 Blockade Through Biomarker Analyses and Development of Novel Combinatorial Strategies Chairperson: Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY Michael Curran, Margaret Callahan, F. Stephen Hodi, Jedd D. Wolchok
09:00:00 Cancer Targets and Discovery Chairperson: Stuart L. Schreiber, Broad Institute of MIT and Harvard, Cambridge, MA Andrea Califano
09:00:00 Cell Cycle Targeting Chairperson: Mariano Barbacid, Spanish National Cancer Research Center (CNIO), Madrid, Spain
09:00:00 Cross-Species Analysis of Mouse and Human Cancer Chairperson: David J. Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Hans-Guido Wendel, Anguraj Sadanandam, Tyler Jacks
09:00:00 Drug Development Track: New Drugs on the Horizon 1 Co-Chairpersons: Lori S. Friedman, Genentech, Inc., South San Francisco, CA, and Simon Bailey, Pfizer, Inc., San Diego, CA Dennis Huszar, Timothy Hoey, Lori S. Friedman
09:00:00 Eighth Annual Undergraduate Student Caucus and Poster Competition Chairperson: Kathleen W. Scotto, UMDNJ-The Cancer Institute of New Jersey, Newark, NJ Donald S Coffey
09:00:00 Career Conversations Basic and Translational Research Career Paths in Pancreatic Cancer Darren R. Carpizo, Channing Der
09:00:00 Techniques for Assessing Circulating Tumor Cells, Circulating DNA, and Exosomes: Pros and Cons Chairperson: Sanjiv Sam Gambhir, Stanford University, Stanford, CA Peter Kuhn, Caroline Dive, Muneesh Tewari, Maximilian Diehn
09:00:00 Small Animal Imaging in Cancer Research Chairperson: H. Charles Manning, Vanderbilt University, Nashville, TN H. Charles Manning, Charles F. Caskey, Jonathan S. Wall
09:00:00 Navigating the Road to a Successful Career in Cancer Research: Professional Advancement Roundtable Rick A. Kittles
09:00:00 Special Program for High School Students: The Conquest of Cancer and the Next Generation of Cancer Researchers Kathleen W. Scotto
09:00:00 WICR Career Mentoring Session Joan S Brugge, Leslie Bernstein
09:00:00 Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Matthew J. Ellis, Tan Ince, Jeremy N. Rich, Michael T. Lewis
09:00:00 Stem Cells, Enteroids, and Organoids: A New Era for In Vitro Models of the Intestine Calvin Kuo, Scott Magness, Toshiro Sato, James M. Wells
09:00:00 Transdisciplinary Cancer Research Teams: If You Build It, Will They Come? Chairperson: Julie A. Ross, University of Minnesota Masonic Cancer Center, Minneapolis, MN Julie Rossie, James F. Amatruda, Joseph L. Wiemels, Stephen M. Schwartz
09:00:00 16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Beverly A. Teicher, Kornelia Polyak, Abenaa M. Brewster, Jennifer Rubin Grandis
09:00:00 Normal and Malignant Stem Cells: New Paradigms Chairperson: Connie J. Eaves, BC Cancer Agency, Vancouver, BC, Canada Mark J. Shackleton, Ravi Bhatia, Connie J Eaves
09:00:00 Using Switchable Mouse Genetics to Identify Cancer Targets Gerard I. Evan, University of Cambridge, Cambridge, United Kingdom Gerard I Evan
09:00:00 Cancer Omics Beyond the Genome Benjamin P. Berman, Sunney Xie
09:00:00 Computational Methods in Molecular Epidemiology Debashis Ghosh, Li Hsu, Kimberly D. Siegmund, Montserrat Garcia-Closas
09:00:00 GWAS: The Next Steps Chairperson: Ellen L. Goode, Mayo Clinic College of Medicine, Rochester, MN Alvaro Monteiro, Stephen B. Gruber
09:00:00 Measuring and Understanding Immune Responses to Cancer Immunotherapy Chairperson: Holden T. Maecker, Stanford University School of Medicine, Stanford, CA Cedryk M. Britten, Holden T. Maecker
09:00:00 Measuring Metabolism in Cancer Chairperson: Ralph J. DeBerardinis, UT Southwestern Medical Center, Dallas, TX Ralph J. DeBerardinis, Sabrina M. Ronen, Christian Metallo, Gary Siuzdak
09:00:00 New Approaches to Imaging Tumor Biology Kevin M. Brindle, Sanjiv S. Gambhir, Vasilis Ntziachristos,, John S Condeelis
09:00:00 Next-Generation Sequencing and Analysis of Genomes Rachel Karchin, Katherine A. Hoadley, Christopher A. Maher
09:00:00 Targeting Cancer Transcription Kimberly Stegmaier, Dana-Farber Cancer Institute, Boston, MA Kimberly Stegmaier
09:00:00 Understanding T-ALL: Models, Mechanisms, and Genomics Adolfo Ferrando, Columbia University, New York, NY Adolfo Ferrando
09:00:00 Using Networks to Genetically Map Biologic Process to Phenotype Kenneth H. Buetow, Arizona State University, Scottsdale, AZ Kenneth H. Buetow
09:00:00 What Has CYP17 Inhibition Taught Us About Prostate and Breast Cancers? Johann S. De Bono, Institute of Cancer Research, Sutton, United Kingdom Johann S. de Bono
09:00:00 Advances in High-Resolution Optical Microscopy Chairperson: Jan T. Liphardt, University of California, Berkeley, CA Jan T. Liphardt
09:00:00 Cancer Methylomes for Biomarker and Pathway Discovery Chairperson: Toshikazu Ushijima, National Cancer Center Research Institute, Tokyo, Japan Chuan He, Christoph Bock, Stephan Beck
09:00:00 Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
09:00:00 RANKL: From Bone Loss to the Regulation of Breast Cancer Josef Penninger, Institute of Molecular Biotechnology, Vienna, Austria
09:00:00 Personalized Medicine in Clinical Trials: What You Need to Know Now Elizabeth Mansfield, U.S. Food and Drug Administration, Rockville, MD Elizabeth Mansfield
09:00:00 PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
09:00:00 New Insights Into p53 From Genetics and Genomics Laura D. Attardi, Stanford University School of Medicine, Stanford, CA L D Attardi,
09:00:00 Matching Mechanism to Management: What Molecular Biology is Teaching Us in Head and Neck Cancer Ezra E. W. Cohen, University of Chicago, Chicago, IL Ezera E.W. Cohen
09:00:00 Mechanisms of Mutant p53 Gain of Oncogenic Function Carol L. Prives, Columbia University, New York, NY
09:00:00 Impact of Genomics on Clinical Cancer Genetics Judy E. Garber, Dana-Farber Cancer Institute, Boston, MA Judy E. Garber
09:00:00 Integrating Proteomics and Genomics to Profile Tumor Phenotypes Daniel C. Liebler, Vanderbilt University, Nashville, TN Daniel C. Liebler
09:00:00 Inter- and Intratumor Heterogeneity in Human Cancer P. Andrew Futreal, The University of Texas MD Anderson Cancer Center, Houston, TX P. Andrew Futreal
09:00:00 Links Between Cancer Cell Metabolism and Epigenetics Kathryn Wellen, Perelman School of Medicine, Philadelphia, PA Kathryn Wellen
09:00:00 Links Between Metabolism and Cancer Chi Van Dang, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA Chi Van Dang
09:00:00 Macrophages as a Therapeutic Target in the Tumor Microenvironment Johanna A. Joyce, Memorial Sloan-Kettering Cancer Center, New York, NY Johanna A. Joyce
09:00:00 Novel Approaches in Allogeneic Bone Marrow Transplantation Marcel Van Den Brink, Memorial Sloan-Kettering Cancer Center, New York, NY
09:00:00 Ovarian Cancer Immunotherapy: Are We There Yet? George Coukos, Ludwig Institute for Cancer Research Ltd, Switzerland George Coukos
09:00:00 Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
09:00:00 Progress in Targeting Chromatin Modifying Enzymes in Cancer Therapy Victoria M. Richon, Sanofi Oncology, Cambridge, MA Victoria M. Richon
09:00:00 The Promise of T Cell Engineering Michel Sadelain, Memorial Sloan-Kettering Cancer Center, New York, NY Michel Sadelain
09:00:00 Somatic Mutation Analyses in Melanoma Yardena Samuels, National Human Genome Research Institute, Bethesda, MD Yardena Samuels
09:00:00 Hereditary Cancer Syndromes Charis Eng, The Cleveland Clinic, Cleveland, OH Charis Eng
09:00:00 Histone Variants and Chromatin Dynamics During the Cell Cycle and in the Context of Cancer Genevieve Almouzni, Institut Curie, Paris, France Genevieve Almouzni
09:00:00 Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
09:00:00 Imatinib as a Paradigm of Targeted Cancer Therapies Brian J. Druker, OHSU Knight Cancer Institute, Portland, OR Brian Druker
09:00:00 Immune Reconstitution Following Lymphodepleting Cancer Therapy: Does It Matter? Crystal L. Mackall, National Cancer Institute, Bethesda, MD Crystal Mackall
09:00:00 Future Anticancer Targets: Put the Cart Before the Horses? Tak W. Mak, Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada Tak W. Mak
09:00:00 Evaluating Positive and Negative Selection in Cancer Genomes Rameen Beroukhim, Dana-Farber Cancer Institute, Boston, MA Rameen Beroukhim
09:00:00 Finding the Best Cancer Targets: Promises and Challenges Frank P. Stegmeier, Novartis, Cambridge, MA
09:00:00 Genetic Epidemiology of Pancreatic Cancer Gloria M. Petersen, Mayo Clinic College of Medicine, Rochester, MN Gloria M. Petersen
09:00:00 GWAS, Sequencing, and Immmunogenomics in Cancer Research Yusuke Nakamura, University of Chicago, Chicago, IL Yusuke NAKAMURA
09:00:00 Cellular Consequences of Aneuploidy and Aneuploidy as a Target for Cancer Therapy Angelika Amon, Massachusetts Institute of Technology, Cambridge, MA Angelika Amon
09:00:00 A Chemo-Genomic Approach to Understand Leukemia Stem Cell Self-Renewal Guy Sauvageau, University de Montréal IRIC, Montréal, QC, Canada Guy Sauvageau
09:00:00 Clonal and Mutation Evolution in Cancer Medicine in the Era of Next-Generation Genome Sequencing Samuel Aparicio, BC Cancer Research Center, Vancouver, BC, Canada Samuel Aparicio
09:00:00 Complementing Angiogenesis Inhibitor Actions on Tumors Donald M. McDonald, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Donald M. McDonald
09:00:00 Considerations for Sequencing Analyses of Cancer Progression and Metastasis Christine A. Iacobuzio-Donahue, Johns Hopkins Hospital, Baltimore, MD Christine A. Iacobuzio-Donahue
09:00:00 Control of Cell State Decisions by Large Noncoding RNAs Mitchell Guttman, Broad Institute of MIT and Harvard, Cambridge, MA Mitchell Guttman
09:00:00 Developing Targeted Therapies in Lung Cancer Alice T. Shaw, Massachusetts General Hospital Cancer Center, Boston, MA Alice T. Shaw
09:00:00 Dysregulated Morphogenesis and Polarity in Cancer Jeffrey L. Wrana, Samuel Lunenfeld Research Institute, Toronto, ON, Canada Jeffrey L. Wrana
09:00:00 ERBB2/HER2: An Update on Signaling, Biology, the Older and Newer Drugs Yosef Yarden, Weizmann Institute of Science, Rehovot, Israel Yosef Yarden
09:00:00 Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
09:00:00 Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin, Xandra O Breakefield, David C Lyden, Zena Werb
09:00:00 Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer, M. Celeste Simon, Anne McTiernan, Thomas N. Seyfried
09:00:00 2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
09:00:00 Analytical Approaches for the Discovery of Patient Selection Biomarkers Kavitha Venkatesan, Novartis Institutes for BioMedical Research, Cambridge, MA
09:00:00 Biomarkers of Resistance to Endocrine Treatments in Breast Cancer Mitchell Dowsett, The Royal Marsden Hospital, London, United Kingdom Mitchell Dowsett
09:00:00 Breast Cancer Genomics: Challenges and Opportunities Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Matthew Ellis
09:00:00 Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
09:00:00 Cancer Disparities Peter Boyle, International Prevention Research Institute, Lyon, France Peter Boyle
09:00:00 Cancer Epigenetics and Epigenetics: Two Sides of the Same Coin? Peter A. Jones, USC/Norris Comprehensive Cancer Center, Los Angeles, CA Peter A. Jones
09:00:00 Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
09:00:00 Cancer Stem Cells/Cancer-Initiating Cells: Signaling and Treatment Approaches Joan Seoane, Vall d'Hebron Institute of Oncology, Barcelona, Spain Joan Seoane
09:00:00 Cell-Based and Patient-Derived Xenografts as Models for Targeted Therapy Maurizio Scaltriti, Memorial Sloan-Kettering Cancer Center, New York, NY
09:00:00 Translational Cancer Research for the Basic Scientist Chairperson: Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium Christos Sotiriou
09:00:00 Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills, Scott A. Armstrong, Louis M. Staudt
09:00:00 PARP Inhibitors in Cancer Therapy Chairperson: Ralph Scully, Beth Israel Deaconess Medical Center, Boston, MA Judy E. Garber, Thomas Helleday, Ralph Scully
09:00:00 Noncoding RNAs in Cancer: From Pathogenesis to Therapeutics Chairperson: Elsa R. Flores, The University of Texas MD Anderson Cancer Center, Houston, TX Michael F. Clarke,, Andrea Ventura, Carlo M Croce, Elsa R. Flores
09:00:00 New Perspectives on Cancer Immune Surveillance Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO Robert D Schreiber
09:00:00 Genetically Engineered Immune Cells in Immunotherapy Chairperson: Carl H. June, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA Carl H. June, Renier J. Brentjens, Charles Sentman
09:00:00 Functional Assessment of Actionable Mutations in Breast Cancer Chairperson: Ron Bose, Washington University School of Medicine, St. Louis, MO Chad Creighton, Samuel Aparicio
09:00:00 From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 4: Oncology Drug Discovery and Development: Combination Therapies Chairperson: Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC Axel Hoos, Amy E. McKee, Paul Workman, Tona M Gilmer
09:00:00 From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 3: Drug Lead Optimization Chairperson: Michael J. Luzzio, Novartis Institutes for BioMedical Research, Cambridge, MA Pierre-Yves Michellys
09:00:00 Nuclear Topology and Transcription Factors: Defining the Architecture of Normal and Malignant Cells Chairperson: Ari M. Melnick, Weill Cornell Medical College of Cornell University, New York, NY Bing Ren, Gerd A. Blobel, Ari M. Melnick
09:00:00 Hypoxia-Induced Metastasis Chairperson: M. Celeste Simon, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA M. Celeste Simon, Amato J. Giaccia, Randall Johnson
09:00:00 Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri, Tyler Curiel
09:00:00 Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial, David M Sabatini, Almut Schulze, Eyal Gottlieb
09:00:00 New Approaches in Molecular Epidemiology Chairperson: Carmen J. Marsit, Dartmouth Medical School, Hanover, NH Bruce S. Kristal, Heather H. Nelson, Carmen J. Marsit, Marylyn D. Ritchie
09:00:00 New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA Andrew J. Phillips, James E. Bradner, Angela Koehler
09:00:00 The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Keiran S. M. Smalley, Lynda Chin, Martin McMahon
09:00:00 p53: Still Controversial After All These Years Chairperson: Carol L. Prives, Columbia University, New York, NY Moshe Oren, Karen Vousden, Wei Gu
09:00:00 Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad, Esther H Chang
09:00:00 Tumor Immunology and Immunotherapy for Non-Immunologists Chairperson: Suzanne Ostrand-Rosenberg, University of Maryland, Baltimore, MD Louis M Weiner, Anna Karolina Palucka, Cassian Yee, Arthur A. Hurwitz
09:00:00 Future Direction in Personalized Medicine for Lung Cancer Chairperson: Tony S. K. Mok, Chinese University of Hong Kong, Shatin, NT, Hong Kong Johan F. Vansteenkiste, Tony S. Mok
09:00:00 From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 2: Targeting Epigenetics: An Epicenter of Oncology Drug Discovery? Chairperson: Ho Man Chan, Novartis Institutes for BioMedical Research, Cambridge, MA Dashyant Dhanak, Jinrong Min
09:00:00 Cancer Genomics in the Clinic Chairperson: John D. Carpten, Translational Genomics Research Institute, Phoenix, AZ John D Carpten
09:00:00 Cancer Immunology for the Non-Immunologist - Tutorial Chairperson: Michael A. Caligiuri, The Ohio State University James Cancer Hospital, Columbus, OH Michael A. Caligiuri
09:00:00 Cancer Prognosis and Survivorship: Novel Strategies and Results Chairperson: Cornelia M. Ulrich, German Cancer Research Center, Heidelberg, Germany Paul B. Jacobsen, Lee Jones, Cornelia M. Ulrich, Thomas Hudson
09:00:00 Cancer Stem Cells: Biologic and Clinical Implications Chairperson: Max S. Wicha, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI Max S Wicha
09:00:00 Central Role of the Mircroenvironment in Initiation and Progression of Tumors and Response to Chemotherapy Chairperson: Mina J. Bissell, Lawrence Berkeley National Laboratory, Berkeley, CA Larry Norton, Frances R. Balkwill, Shahin Rafii, Mina J Bissell
09:00:00 Change for the Worse: Premalignant Metaplasia in the Stomach, Esophagus, and Pancreas Chairperson: Steven D. Leach, Johns Hopkins University School of Medicine, Baltimore, MD Steven D. Leach, Anil K Rustgi, Jason Mills
09:00:00 Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry, George W Sledge, Jr.
09:00:00 Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Neal Rosen, Ravi Amaravadi, Anthony G. Letai
09:00:00 Deconstructing the Complexity of Triple-Negative Breast Cancer Chairperson: Jorge Reis-Filho, Memorial Sloan-Kettering Cancer Center, New York, NY Jennifer A. Pietenpol, Jorge Reis-Filho, William Foulkes
09:00:00 DNA Damage Response: What Do We Know Now and What Will We Learn Next? Chairperson: Junjie Chen, The University of Texas MD Anderson Cancer Center, Houston, TX Michael B Kastan, Helen M. Piwnica-Worms, Jiri Bartek, Junjie Chen
09:00:00 Epigenetic Regulators in Hematology: From Stem Cells to Malignancies Chairperson: Ross L. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Guido Marcucci, Anwesha Dey, Guy Sauvageau
09:00:00 Epithelial Stem Cells, Morphogenesis, and Cancer Chairperson: Ian G. Macara, University of Virginia School of Medicine, Charlottesville, VA Senthil K. Muthuswamy, Lindsay Hinck, Robert J. Coffey, Jr., Ian G. Macara
09:00:00 From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Thomas F Gajewski, Ross L. Levine, Kwok-Kin Wong
09:00:00 Can Mouse Cancer Models Improve Clinical Medicine? Chairperson: David A. Tuveson, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY Edison T Liu, David A Tuveson
09:00:00 Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Maura L. Gillison, Peter M Howley, Richard B. Roden, Aimee Kreimer
09:00:00 Cancer in the Adolescent and Young Adult Population George D. Demetri
09:00:00 Circulating Tumor Cells versus Serum DNA Josep Tabernero
09:00:00 Clinical Trials Based on Mutations versus Histology William R Sellers, Charles L Sawyers, Lewis C Cantley
09:00:00 Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White, Michael Morrissey, Frank McCormick
09:00:00 The MICR Forum: Precision Medicine in Cancer: Will There Be Equitable Benefits? William G. Nelson
09:00:00 Next-Generation Sequencing in the Clinic Moderator: Michael F. Berger, Memorial Sloan-Kettering Cancer Center, New York, NY
09:00:00 Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY Elaine Mardis, James H. DOROSHOW, David B. Solit, Andrea Califano
09:00:00 The Role of Stroma in Pancreatic Cancer Moderator: Kornelia Polyak, Dana-Farber Cancer Institute, Boston, MA Philip A Beachy, Ben Stanger
09:00:00 Stem Cells in Cancer Moderator: Sean J. Morrison, UT Southwestern Medical Center, Dallas, TX Cedric Blanpain, Richard J Gilbertson
09:00:00 The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Jeremy N. Rich, Jos Jonkers, Mathew Garnett, Levi A Garraway
09:00:00 Endocrine Resistance in Breast Cancer Chairperson: Nancy E. Davidson, University of Pittsburgh Cancer Institute, Pittsburgh, PA Douglas none Yee, Steffi Oesterreich Oesterreich, Matthew P . Goetz, Nancy E Davidson
09:00:00 Epigenetic Mechanisms of Cancer Risk Chairperson: Matthew L. Freedman, Dana-Farber Cancer Institute, Boston, MA Peter Scacheri, Matthew L. Freedman, Megan P. Hitchins, Andrew P. Feinberg
09:00:00 Metformin, Phenformin, Diabetes, and Cancer Alistair Thompson, Phillip A. Dennis, Michael Pollak
09:00:00 Nanotechnology Approaches to the Treatment of Cancer David Morrissey, Scott Eliasof, Warren Chan, Mark E Davis
09:00:00 Next-Generation Therapeutic Modeling in Mice Pier Paolo, Jos Jonkers, Cory Abate Shen, Allan Balmain
09:00:00 Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY Antoni Ribas, Carl H. June, James A. Fagin, W. Marston Linehan
09:00:00 Using Genomics to Guide Cancer Immunotherapy Chairperson: Robert D. Schreiber, Washington University School of Medicine, St. Louis, MO Ugur Sahin, Pramod K. Srivastava, Robert D Schreiber, James P Allison
09:00:00 Clinical Trials with Functional Foods Chairperson: Thomas W. Kensler, University of Pittsburgh, Pittsburgh, PA Gary D. Stoner, Thomas W. Kensler, Jed W. Fahey
09:00:00 Antibody-Drug Conjugates Come of Age Hans-Peter Gerber, Ho Sung Cho, Beverly A Teicher, John T Hunt
09:00:00 Avatar: Individualized Human Cancer Models in Mice David Sidransky, Kwok-Kin Wong, Livio Trusolino
09:00:00 Current Concepts on Aging, Telomeres, and Cancer Ronald A. DePinho, Jerry Shay, Carol Greider
09:00:00 Pediatric Cancer: From Susceptibility to Targeted Therapies Co-Chairpersons: Katherine K. Matthay, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, and John M. Maris, Children's Hospital of Philadelphia, Philadelphia, PA David H Rowitch
09:00:00 Prostate Cancer Screening: Now and In the Future Co-Chairpersons: William G. Nelson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, and Mark A. Rubin, Weill Cornell Medical College of Cornell University, New York, NY William G. Nelson, Mark A Rubin, Otis W. Brawley, Fritz H Schröder
09:00:00 Targeting Lymphoid Malignancies: Working from the Outside In Co-Chairpersons: John P. Leonard, Weill Cornell Medical Center, New York, NY, and John C. Byrd, The Ohio State University Comprehensive Cancer Center, Columbus, OH John P. Leonard, John C. Byrd, James R. Cerhan
09:00:00 Novel Mechanisms of Cancer Genomic Alteration Michael R STRATTON, Tatsuhiro Shibata, Adam Bass, Jan Korbel
09:00:00 Pancreatic Adenocarcinoma: Progress and Challenges in Delineating Molecular and Structural Complexities Co-Chairpersons: Sean Grimmond, The University of Queensland, St. Lucia, Australia, and Karen M. Mann, Methodist Hospital Research Institute, Houston, TX Sean M Grimmond, Sunil R Hingorani
09:00:00 The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Brian J Reid, Carlo C Maley, Frank McKeon, Timothy C. Wang
09:00:00 Myeloid Malignancies Co-Chairpersons: Ari M. Melnick, Weill Cornell Medical College of Cornell University, New York, NY, and Timothy Graubert, Washington University School of Medicine, St. Louis, MO Ari M. Melnick, Omar I. Abdel-Wahab, Ulrich G. Steidl
09:00:00 The Molecular Basis for Improvement in Endometrial Cancer Therapy Co-Chairpersons: Cheryl Lyn Walker, Texas A&M University Health Science Center, Houston, TX, and Douglas A. Levine, Memorial Sloan-Kettering Cancer Center, New York, NY Karen H. Lu, George Mills, Douglas A. Levine
09:00:00 Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Yibin Kang, Theresa Guise, Russell S. Taichman, Matthew Smith
09:00:00 Lymphoid Malignancies Co-Chairpersons: Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom, and Louis M. Staudt, National Cancer Institute, Bethesda, MD Louis M. Staudt, Riccardo Dalla Favera, Mignon Loh, Peter Campbell
09:00:00 Epigenetic Mechanisms in Gastrointestinal Differentiation and Malignant Transformation Chairperson: Ramesh A. Shivdasani, Dana-Farber Cancer Institute, Boston, MA Manel Esteller, Jan Paul Medema, Peter Lewis
09:00:00 Latent Metastasis Co-Chairpersons: Klaus Pantel, University Medical Center Hamburg, Hamburg, Germany, and Frank J. Rauscher III, The Wistar Institute, Philadelphia, PA Klaus Pantel, Catherine Alix-Panabières, Julio Aguirre-Ghiso
09:00:00 Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, Joan Massagué, William C Hahn, Ann F. Chambers
09:00:00 New Therapeutic Targets for Ewing’s Sarcoma Co-Chairpersons: Arul M. Chinnaiyan, University of Michigan, Ann Arbor, MI, and Edwin Choy, Massachusetts General Hospital, Boston, MA Lee J. Helman, Arul M Chinnaiyan, Ivan Stamenkovic
09:00:00 Emerging Targets in the Treatment of Lung Cancer Co-Chairpersons: William Pao, Vanderbilt University, Nashville, TN, and Matthew L. Meyerson, Dana-Farber Cancer Institute, Boston, MA Roman K. Thomas, William Pao, Matthew L. Meyerson
09:00:00 New Approaches to Drug Discovery Chairperson: William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA Thomas Franch, Eric Martin, Michael J. Eck
09:00:00 New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff, Harpreet Singh-Jasuja, Cornelis J.M. Melief
09:00:00 Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Phillip Sharp, Howard Y. Chang, Jeannie T. Lee, Joshua Mendell
09:00:00 Obesity, Energy Balance, and Metabolism Chairperson: Eileen P. White, UMDNJ-The Cancer Institute of New Jersey, New Brunswick, NJ Stephen D. Hursting, Andrew J. Dannenberg, David M Sabatini
09:00:00 The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Ervin H. Epstein, Masashi Narita, Wei Gu, Kornelia Polyak
09:00:00 The Ruth Sager Memorial Symposium: Cancer Heterogeneity Chairperson: Elaine Mardis, Washington University School of Medicine, St. Louis, MO Charles Swanton, Peter Campbell, William Pao, Elaine Mardis
09:00:00 The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Douglas Greene, Simone Fulda, Rod Humerickhouse, Anthony G. Letai
09:00:00 Strategies to Overcoming Drug Resistance Chairperson: David Uehling, Ontario Institute for Cancer Research, Toronto, ON, Canada Carlos L. Arteaga, Janet E. Dancey
09:00:00 Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati, Katherine A. Hoadley, Chris Sander, Lynda Chin
09:00:00 Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Scott W. Lowe, Stephen J Elledge, Julian Downward, Alan Ashworth
09:00:00 Target Validation by Chemical Probes/Designer Chemical Probes and Phenotypic Approach to Drug Discovery Chairperson: Michael A. Foley, Broad Institute of MIT and Harvard, Cambridge, MA Tim Clackson, Alykhan F. Shamji, John Tallarico, Kevan M Shokat
09:00:00 Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Tom Curran, Suzanne J. Baker, Cameron W Brennan, Claudia Petritsch
09:00:00 Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Constantinos Koumenis, Karen Cichowski, Davide Ruggero, Nahum Sonenberg
09:00:00 Use of Next-Generation Sequencing: Implementation of Clinical Genomics Chairperson: David B. Solit, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony John Iafrate, John D Carpten, Arul M Chinnaiyan, David B. Solit
09:00:00 The Breast Cancer Genome and Its Implications for Therapy Co-Chairpersons: José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY, and Joe W. Gray, Oregon Health and Science University Knight Cancer Institute, Portland, OR Carlos Caldas, Jorge Reis-Filho
09:00:00 Classification and Pathogenesis of Liver Cancers Co-Chairpersons: Josep Llovet, Mt. Sinai School of Medicine, New York, NY, and Jessica Zucman-Rossi, Inserm, Paris, France Josep Llovet, Michael Karin, Lars Zender, Jessica Zucman-Rossi
09:00:00 Current Concepts on Emerging Targets in the Treatment of Melanoma Co-Chairpersons: Keith Thomas Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA, and Boris C. Bastian, UCSF Cardiovascular Research Institute, San Francisco, CA Andrew E. Aplin, Keith T Flaherty
09:00:00 Liquid Biopsies to Monitor Response and Resistance to Targeted Therapies Chairperson: Alberto Bardelli, Fondazione Piemontese per la Ricerca sul Cancro ONLUS, Candiolo, Italy Alberto Bardelli, Nitzan Rosenfeld, Ben H. Park
09:00:00 Mathematical Modeling and Cancer Evolution Chairperson: Carlo C. Maley, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
09:00:00 Metabolic Changes Associated with Ras-Drive Cancers Chairperson: Dafna Bar-Sagi, New York University Langone Medical Center, New York, NY Dafna Bar-Sagi, David Tuveson
09:00:00 Metabolic Inputs into Cancer Epigenetics Chairperson: Craig B. Thompson, Memorial Sloan-Kettering Cancer Center, New York, NY Craig B. Thompson, Scott Bultman, Karen Vousden, Kun-Liang Guan
09:00:00 Metabolic Vulnerabilities of Cancer Cells Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Ralph J. DeBerardinis, Eyal Gottlieb
09:15:00 From Discovery Science to Precision Medicine: Paving the Path to Progress (Plenary Session)
12:30:00 NCI Funding and Training Opportunities in Cancer Research (NCI/NIH-Sponsored Session)
12:45:00 Noncoding RNAs and Cancer (Major Symposium)
13:00:00 Cross-Species Analysis of Mouse and Human Cancer (Major Symposium)
13:30:00 Breast Cancer and the Environment: Prioritizing Prevention (NCI/NIH-Sponsored Session)
14:00:00 Basic and Translational Research Career Paths in Pancreatic Cancer (Meet the Research Pioneer)
14:00:00 Advancing Scientific Progress through Genomic Data Sharing: Access and Analysis (NCI/NIH-Sponsored Session)
14:00:00 Meet the MICR Council (Meet and Greet)
15:15:00 A Conversation on a Decade of Oncology Drug Development: Perspectives from FDA Oncologic Drug Advisory Committee (ODAC) Chairs (Science Policy Session)
15:15:00 New SU2C Dream Teams: Patient Benefit Through Targeted Therapeutics and Immunotherapy (Special Session)
15:30:00 Meet the Mentor: Undergraduate Focus (Meet and Greet)
15:30:00 Federally Supported Cancer Biospecimen Resources Available to the Research Community (NCI/NIH-Sponsored Session)
15:45:00 Funding Opportunities in Europe for Creative Minds from Anywhere in the World (Special Session)
16:15:00 Eighth Annual AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship (Lecture)
17:00:00 25th Anniversary Celebration of Associate Membership (Special Session)
17:30:00 Presidential Address: The End of K-RAS Cancers? (Lecture)
18:00:00 Chemistry in Cancer Research (CICR) Town Meeting (Town Meeting)
18:00:00 Cancer Immunology (CIMM) Town Meeting (Town Meeting)
18:30:00 Professional Networking: The Gateway to Scientific Collaborations (Professional Advancement Session)
21:00:00 Clonal Evolution of Cancer Chairperson: Matthew J. Walter, Washington University School of Medicine, St. Louis, MO Charles Swanton, Catherine J. Wu, Matthew J. Walter, Carlo C. Maley
Monday, April 8, 2013
06:45:00 2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics (Meet-the-Expert Session)
08:00:00 Epigenetic Targets for Cancer (Plenary Session)
08:15:00 WICR Career Mentoring Session (Professional Advancement Session)
09:00:00 EPIGENETIC TARGETS FOR CANCER Robert A. Copeland, James E. Bradner, Anjana Rao, Peter W Laird
10:00:00 Special Lecture by the NCI Director (Lecture)
12:45:00 Realizing Patient Benefit: Three-Year Results From the SU2C Dream Teams (Special Session)
13:00:00 NCI’s Center for Strategic Scientific Initiatives (CSSI): Programs and Highlights (NCI/NIH-Sponsored Session)
13:00:00 Current Concepts on Aging, Telomeres, and Cancer (Current Concepts in Diagnostics and Therapeutics Research)
14:30:00 Basic and Translational Research Career Paths in Pancreatic Cancer (Career Conversations)
14:30:00 Meet the AACR Chief Executive Officer: Margaret Foti (Meet and Greet)
14:30:00 MICR Forum: Precision Medicine in Cancer: Will There Be Equitable Benefits? (Forum)
15:00:00 A Conversation on Oncology Drug Development: An International Regulatory Perspective from the United States, the European Union, and Canada (Science Policy Session)
15:30:00 Ninth Annual AACR-Irving Weinstein Foundation Distinguished Lectureship (Lecture)
15:45:00 NCI Resources For Imaging Research (NCI/NIH-Sponsored Session)
16:30:00 Seventh Annual AACR Princess Takamatsu Memorial Lectureship (Lecture)
17:00:00 2013 AACR/ASCO Joint Symposium: Current Challenges in Clinical Trials (Major Symposium)
17:30:00 Sixteenth Annual Pezcoller Foundation-AACR International Award for Cancer Research (Lecture)
18:00:00 Joint Cancer Immunology (CIMM)/Tumor Microenvironment (TME) Working Groups Evening Scientific Session: Innate Responses and the Tumor Microenvironment (Special Session)
18:00:00 Molecular Epidemiology (MEG) Town Meeting (Town Meeting)
18:30:00 Navigating the Road to a Successful Career in Cancer Research: Professional Advancement Roundtable (Professional Advancement Session)
Tuesday, April 9, 2013
07:00:00 Cancer Stem Cells/Cancer-Initiating Cells: Signaling and Treatment Approaches (Meet-the-Expert Session)
08:00:00 The HMO Cancer Research Network: A Research Resource within Health Care Delivery Systems (NCI/NIH-Sponsored Session)
08:15:00 BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? (Major Symposium)
08:30:00 Special Program for High School Students: The Conquest of Cancer and the Next Generation of Cancer Researchers (Professional Advancement Session)
09:30:00 Alliance of Glycobiologists for Detection of Cancer: A Trans-NIH Initiative for Cancer Glycobiology (NCI/NIH-Sponsored Session)
10:30:00 Frederick National Laboratory for Cancer Research: R&D Capabilities and Collaboration Opportunities (NCI/NIH-Sponsored Session)
10:30:00 Avatar: Individualized Human Cancer Models in Mice (Current Concepts in Diagnostics and Therapeutics Research)
11:00:00 Navigating Careers in Science Policy (Career Conversations)
12:00:00 NCI Resources to Catalyze Drug Development for Cancer Treatment and Prevention (NCI/NIH-Sponsored Session)
12:30:00 Special Topics in Cancer Research: Your Role in Advocacy (Career Conversations)
13:00:00 Analysis of Cancer Genome Data: From Evolution to Pathways and Networks (Major Symposium)
13:30:00 Funding Opportunities for Cancer Research at Multiple NIH Institutes and Centers with NIH experts. (NCI/NIH-Sponsored Session)
14:00:00 Meet the Jane Cooke Wright Lecturer (Meet and Greet)
15:00:00 Back to the Future: Next Generation Vaccination and Cellular Immune Therapies (Minisymposium)
15:00:00 Seventh Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research (Lecture)
15:30:00 Technology Transfer and Intellectual Property: Financial and Career Opportunities for Researchers (NCI/NIH-Sponsored Session)
15:30:00 Meet NCI-CRCHD Representatives (Meet and Greet)
16:00:00 Eighteenth Annual AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research (Lecture)
16:30:00 Policy Report from the Institute of Medicine's National Cancer Policy Forum (Science Policy Session)
17:00:00 Circulating Tumor Cells versus Serum DNA (Forum)
18:30:00 Tumor Microenvironment (TME) Town Meeting (Town Meeting)
Wednesday, April 10, 2013
07:00:00 Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy (Meet-the-Expert Session)
08:00:00 Cancer Evolution and Resistance (Plenary Session)
09:00:00 CANCER EVOLUTION AND RESISTANCE René Bernards, Todd R. Golub, Neal Rosen, Jeffrey A Engelman
10:00:00 AACR-CRI Lloyd J. Old Award in Cancer Immunology (Lecture)
10:00:00 Opportunities and Challenges for Cancer Health Disparities Research in Large Collaborative Studies (NCI/NIH-Sponsored Session)
11:00:00 Antibody-Drug Conjugates Come of Age (Current Concepts in Diagnostics and Therapeutics Research)
11:30:00 TARGETing Better Treatments for Childhood Cancers: A Progress Report on the NCI’s Therapeutically Applicable Research to Generate Effective Treatments Initiative (NCI/NIH-Sponsored Session)
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.